Anon. (1986). Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal of the European CommunitiesL358, 1–29.
2.
SpielmannH., LovellW.W., HölzleE., JohnsonB.E., MaurerT., MirandaM.A., PapeW.J.W., SaporaO., & SladowskiD. (1994). In vitro phototoxicity testing. The report and recommendations of ECVAM workshop 2. ATLA22, 314–348.
3.
SpielmannH., BallsM., DupuisJ., PapeW.J., PechovitchG., de SilvaO., HolzhütterH-G., ClothierR., DesolleP., GerberickF., LiebschM., LovellW.W., MaurerT., PfannenbeckerU., PotthastJ.M., CsatoM., SladowskiD., SteilingW., & BrantomP. (1998). The international EU/COLIPA in vitro phototoxicity validation study: results of phase II (blind trial). Part 1: the 3T3 NRU phototoxicity test. Toxicology in Vitro12, 305–327.
4.
SpielmannH., BallsM., DupuisJ., PapeW.J.W., de SilvaO., HolzhütterH-G., GerberickF., LiebschM., LovellW. W., & PfannenbeckerU. (1998). A study on UV filter chemicals from Annex VII of European Union Directive 76/768/EEC, in the in vitro 3T3 NRU phototoxicity test. ATLA26, 679–708.
5.
Anon (2000). Guidance for Industry: Photosafety Testing.U.S. Department of Health and Human Services - Food and Drug Administration, Center for Drug Evaluation and Research (CDER), January 2000, Pharmacology and Toxicology; Rockville, MD (USA). Web site http://www.fda.gov/cder/guidance/index.htm.
6.
JohnsonB.E. (1987). Light sensitivity associated with drugs and chemicals. In The Physiology and Pathology of the Skin (ed. JarretA.), pp. 2541–2606. San Diego, CA, USA: Academic Press.
7.
JohnsonB.E. (1992). Drug and chemical photosensitization. In The Environmental Threat to the Skin (ed. MarksR., & PlewigG.), pp. 57–66. London, UK: Martin Dunitz.
8.
SpikesJ.D. (1989). Photosensitization. In The Science of Photobiology (ed. SmithK.C.), 2nd edn, pp. 79–110. New York, USA: Plenum Press.
9.
PendlingtonR.U., & BarratK.R. (1990). Molecular basis of photocontact allergy. International Journal of Cosmetic Sciences12, 91–103.
10.
LehmannP. (1991). Die deutschsprachige Arbeitsgemeinschaft Photopatch-Test (DAPT). Hautarzt41, 295–297.
11.
HölzleE., NeumannN., HausenB., PrzybillaB., SchauderS., & HonigsmannH. (1991). Photopatch testing: the 5-year experience of the German, Austrian, and Swiss Photopatch Test Group. Journal of the American Academy of Dermatology25, 59–68.
12.
NeumannN.J., HölzleE., PlewigG., SchwarzT., PanizzonR.G., BreitR., RuzickaT., & LehmannP. (2000). Photopatch-testing: the 12-years experience of the German, Austrian, and Swiss photopatch test group. Journal of the American Academy of Dermatology, in press.
13.
NeumannN.J., HölzleE., LehmannP., BenedikterS., TapernouxB., & PlewigG. (1994). Pattern analysis of photopatch test reactions. Photodermatology Photoimmunology and Photomedicine10, 65–73.
14.
RungerT.M., LehmannP., NeumannN.J., MatthiesC., SchauderS., & OrtelB. (1995). Empfehlungen einer Photopatch-Test Standardreihe durch die deutschsprachige Arbeitsgruppe “Photopatch-Test”. Hautarzt46, 240–243.
15.
BallsM., BlaauboerB.J., FentemJ., BrunerL., CombesR.D., EkwallB., FielderR.J., GuillouzoA., LewisR.W., LovellD.P., ReinhardtC.A., RepettoG., SladowskiD., SpielmannH., & ZuccoF. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM Workshop 5. ATLA23, 129–147.
16.
OECD (1996). Final Report of the OECD Workshop on Harmonization of Validation and Acceptance Criteria for Alternative Toxicological Test Methods, 60 pp. Paris, France: OECD.
17.
SpielmannH., BallsM., DöringB., HolzhütterH.G., KalweitS., KlecakG., L'EplattenierH., LiebschM., LovellW.W., MaurerT., MoldenhauerF., MooreL., PapeW., PfannbeckerU., PotthastJ., de SilvaO., SteilingW., & WillshawA. (1994). EEC/COLIPA project on in vitro phototoxicity testing: first results obtained with a Balb/c 3T3 cell phototoxicity assay. Toxicology in Vitro8, 793–796.
18.
WakuriS., TanakaN., & OnoH. (1995). In vitro phototoxicity assay using culture cells. Proceedings of the 8th Annual Meeting of the JSAAE in Tokyo 1994; abstract p.19. AATE (Alternatives to Animal Testing and Experimentation)3, 67.
19.
Anon (2000). Commission Directive 2000/33/EC of 25 April 2000, adapting to technical progress for the 27th time Council Directive 67/548/EEC on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. ANNEX II: B.41. In vitro 3T3 NRU Phototoxicity Test. Official Journal of the European CommunitiesL136, 90–107.
20.
ClothierR., WillshawA., CoxH., GarleM., BowlerH., & CombesR. (1999). The use of human keratinocytes in the EU/COLIPA international in vitro phototoxicity test validation study and the ECVAM/COLIPA study on UV filter chemicals. ATLA27, 247–259.
21.
EdwardsS.M., DonnellyT.A., SayreR.M., RheinsL.A., SpielmannH., & LiebschM. (1994). Quantitative in vitro assessment of phototoxicity using a human skin model: Skin2. Photodermatology Photoimmunology and Photo-medicine10, 111–117.
22.
LiebschM., DöringB., DonnellyT.A., LogemannP., RheinsL.A., & SpielmannH. (1995). Application of the human dermal model Skin2 ZK 1350 to phototoxicity and skin corrosivity testing. Toxicology in Vitro9, 557–562.
23.
RoguetR., CohenC., & RougierA. (1994). A reconstituted human epidermis to assess cutaneous irritation, photoirritation and photoprotection in vitro. In Alternative Methods in Toxicology, Vol. 10, In Vitro Skin Toxicology — Irritation, Phototoxicity, Sensitization (ed. RougierA., GoldbergA., & MaibachH.), pp. 141–149. New York, USA: Mary Ann Liebert.
24.
ApiA.M. (1997). In vitro assessment of phototoxicity. In Vitro Toxicology10, 339–350.
25.
LiebschM., BarrabasC., TraueD., & SpielmannH. (1997). Entwicklung eines neuen in vitro Tests auf dermale Phototoxizität mit einem Modell menschlicher Epidermis, EpiDerm™. Alternativen zu Tierexperimenten (ALTEX)14, 165–174.
26.
LiebschM., TraueD., BarrabasC., SpielmannH., GerberickG.F., CruseL., DiembeckW., PfannenbeckerU., SpiekerJ., HolzhütterH-G., BrantomP., AspinP., & SoutheeJ. (1999). Prevalidation of the EpiDerm Phototoxicity Test. In Alternatives to Animal Testing II: Proceedings of the Second International Scientific Conference Organised by the European Cosmetic Industry, Brussels, Belgium (ed. ClarkD., LisanskyS., & MacmillanR.), pp. 160–166. Newbury, UK: CPL Press.
27.
JonesP., KingA., LovellW., & EarlL. (1999). Phototoxicity testing using 3-D reconstructed human skin models. In Alternatives to Animal Testing II: Proceedings of the Second International Scientific Conference Organised by the European Cosmetic Industry, Brussels, Belgium, (ed. ClarkD., LisanskyS., & MacmillanR.), pp. 138–141. Newbury, UK: CPL Press.
28.
BernardF.X., BarraultC., DegueryA., de WeverB., & RosdyM. (1999). Development of a highly sensitive phototoxicity assay using the reconstructed human epidermis SkinEthik. In Alternatives to Animal Testing II: Proceedings of the Second International Scientific Conference Organised by the European Cosmetic Industry, Brussels, Belgium (ed. ClarkD., LisanskyS., & MacmillanR.), pp. 167–174. Newbury, UK: CPL Press.
29.
AugustinC., CollombelC., & DamourO. (1997). Use of dermal equivalent and skin equivalent models for identifying phototoxic compounds in vitro. Photodermatology Photoimmunology and Photomedicine13, 27–36.
30.
PapeW.J.W., MaurerT., PfannenbeckerU., & SteilingW. (2000). The red blood cell phototoxicitytest (photohaemolysis and haemoglobin oxidation): EU/COLIPA validation programme on phototoxicity (Phase II). ATLA, in press.
31.
PapeW.J.W., BrandtM., & PfannenbeckerU. (1994). Combined in vitro assay for photo-haemolysis and haemoglobin oxidation as part of a phototoxicity test system assessed with various phototoxic substances. Toxicology in Vitro8, 755–757.
32.
KahnG., & FleischakerB.I. (1971). Red blood cell haemolysis by photosensitizing compounds. Journal of Investigative Dermatology56, 85–90.
33.
JohnsonB.E., WalkerE.M., & HetheringtonA.M. (1986). In vitro models for cutaneous phototoxicity. In Skin Models: Models to Study Function and Disease of Skin (ed. MarksR., & PlewigG.), pp. 264–281. Berlin, Germany: Springer-Verlag.
34.
TraynorN.J., JohnsonB.E., & GibbsN.K. (1996). Photohaemolysis assay for drug phototoxicity complicated by “bleaching of released haemoglobin”. Toxicology in Vitro10, 619–624.
35.
OkamotoY., RyuA., & OhkoshiK. (1999). In vitro alternatives and phototoxicity testing. I. Evaluation of in vitro phototoxicity assays. ATLA27, 639–644.
36.
WinterbournC.C. (1986). Free-radical production and oxidative reactions of haemoglobin. Environmental Health Perspectives64, 321–330.
37.
AverbeckD., & MoustacchiE. (1991). Response to ultraviolet radiation in a simple eukaryote (yeast): genetic control and biological consequences. In Laboratory Manual, NATO ASI Series: Photobiological Techniques (ed. Pot-tierR.H., DouglasR.H., MathisP., & ValenzenoD.P.), pp. 165–186. New York, USA: Plenum Press.
38.
FriedbergE.C., WalkerG.C., & SiedeW. (1995). DNA Repair and Mutagenesis, pp. 1–698. Washington, DC, USA: ASM Press.
39.
ChételatA., AlbertiniS., DrespJ.H., StrobelR., & GockeE. (1993). Photomutagenesis test development. I. 8-Methoxypsoralen, chlorpromazine and sunscreen compounds in bacterial and yeast assays. Mutation Research292, 241–250.
40.
MorlièreP., HönigsmannH., AverbeckD., DardalhonM., HüppeG., OrtelB., SantusR., & DubertretL. (1988). Phototherapeutic, photo-biologic and photosensitizing properties of khellin. Journal of Investigative Dermatology90, 720–724.
41.
AverbeckD., AverbeckS., DubertretL., YoungA.R., & MorlièreP. (1990). Genotoxicity of bergapten and bergamot oil in Saccharomyces cerevisiae. Journal of Photochemistry and Photo-biology B: Biology7, 209–230.
42.
MoysanA., MorlièreP., AverbeckD., & DubertretL. (1993). Evaluation of phototoxic and photogenotoxic risk associated with the use of photosensitizers in suntan preparations: application to tanning preparations containing bergamot oil. Skin Pharmacology6, 282–291.
43.
CarlsN., & SchiestlR.H. (1994). Evaluation of the yeast DEL assay with 10 compounds selected by the International Program on Chemical Safety for the evaluation of short-term tests for carcinogens. Mutation Research — DNA Repair320, 293–303.
44.
GalliA., & SchiestlR.H. (1998). Effect of Salmonella assay negative and positive carcinogens on intrachromosomal recombination in S-phase arrested yeast cells. Mutation Research419, 53–68.
45.
DeanS.W., LaneM., DunmoreR.H., RuddockS.P., MartinC.N., KirklandD.J., & LoprienoN. (1991). Development of assays for the detection of photomutagenicity of chemicals during exposure to UV light. I. Assay development. Mutagenesis6, 335–341.
46.
AverbeckD. (1985). Relationship between lesions photoinduced by mono- and bifunctional furocoumarins in DNA and genotoxic effects in diploid yeast. Mutation Research148, 217–233.
47.
AverbeckD. (1989). Yearly review: recent advances in psoralen phototoxicity mechanism. Photochemistry and Photobiology50, 859–882.
48.
KnowlandJ., McKenzieE.A., McHughP.J., & CridlandN.A. (1993). Sunlight-induced mutagenicity of a common sunscreen ingredient. FEBS Letters324, 309–313.
49.
MarrotL., BelaidiJ.P., ChauboC., MeunierJ.R., PerezP., & Agapakis-CausseC. (1998). An in vitro strategy to evaluate the phototoxicity of solar UV at the molecular and cellular level: application to photoprotection assessment. European Journal of Dermatology8, 403–412.
50.
MarrotL., & Agapakis-CausseC. (2000). Differences in the photogenotoxic potential of two fluoroquinolones as shown in diploid yeast strain (Saccharomyces cerevisae) and supercoiled plasmid DNA. Mutation Research468, 1–9.
51.
Agapakis-CausseC., BoscaF., CastellJ.V., HernandezD., MarinM.L., MarrotL., & MirandaM.A. (2000). Tiaprofenic acid-photosensitized damage to nucleic acids: a mechanistic study using complementary in vitro approaches. Photochemistry and Photobiology71, 499–505.
52.
AverbeckD., & AverbeckS. (1994). Induction of the genes RAD54 and RNR2 by various DNA damaging agents in Saccharomyces cerevisiae. Mutation Research – DNA Repair315, 123–138.
53.
DubertretL., SantusR., & MorlièreP. eds (1995). Ozone, Sun, Cancer, Molecular and Cellular Mechanisms. Prevention, pp. 1–223. Paris, France: INSERM.
54.
KrutmanJ., AhrendsC., RozaL., & ArlettC.F. (1996). The role of DNA damage and repair in ultraviolet B radiation-induced immunomodulation: relevance for human photocarcinogenesis. Photochemistry and Photobiology63, 394–396.
55.
FirketH., LeclercqJ., & GeubelleF. (1971). A simplified procedure for the use of the “blast-like transformation” of lymphocytes in cultures as a routine clinical test: results in a group of allergic children. Acta Allergologica26, 191–199.
56.
HomeyB., von SchillingC., BluemelJ., SchuppeH.C., RuzickaT., AhrH.J., LehmannP., & VohrH.W. (1998). An integrated model for the differentiation of chemical-induced allergic and irritant skin reactions. Toxicology and Applied Pharmacology153, 83–94.
57.
UlrichP., HomeyB., & VohrH.W. (1998). A modified local lymph node assay for the differentiation of contact photoallergy from phototoxicity by analysis of cytokine expression in skin-draining lymph node cells. Toxicology125, 149–168.
58.
VohrH.-W., BlümelJ., BlotzA., HomeyB., & AhrH.J. (2000). An intra-laboratory validation of the integrated model for the differentiation of skin reactions (IMDS): discrimination between (photo)allergic and (photo)irritant skin reactions in mice. Archives of Toxicology73, 501–509.
59.
KaidbeyK.H., & KilgmanA.M. (1980). Pho-tomaximisation test for identifying photoallergic contact sensitisers. Contact Dermatitis6, 161–169.
60.
HarberL.C., TargovnikS.E., & BaerR.L. (1967). Contact photosensitivity patterns to halogenated salicylanilides in man and guinea-pigs. Archives of Dermatology96, 646–656.
61.
MorikawaF., NakayamaY., FukudaM., HamanoM., YokoyamaY., NaguraT., IshiharaM., & TodaK. (1974). Techniques for evaluation of phototoxicity and photoallergy in laboratory animals and man. In Sunlight and Man (ed. FitzpatrickT.B., PathakM.A., HarberL.C., SeijiM., & KukitaA.), pp. 529–557. Tokyo, Japan: University of Tokyo Press.
62.
GerberickG.F., & RyanC.A. (1989). Contact photoallergy testing of sunscreens in guinea-pigs. Contact Dermatitis20, 251–259.
LovellW. W., & SandersD.J. (1990). Dose-response study of ultraviolet-radiation for induction of photoallergy to tetrachlorosalicylanilide in guinea-pigs. Photodermatology7, 192–197.
65.
MaguireH.C., & KaidbeyK. (1982). Experimental photoallergic contact dermatitis A mouse model. Journal of Investigative Dermatology79, 147–152.
66.
MiyachiY., & TakigawaM. (1983). Mechanisms of contact photosensitivity in mice III predictive testing of chemicals with photoallergenic potential in mice. Archives of Dermatology119, 736–739.
67.
GerberickG.F., & RyanC.A. (1990). A predictive mouse ear swelling model for investigating topical photoallergy. Food and Cemical Toxicology28, 361–368.
68.
GerberickG.F., & RyanC.A. (1990). Use of UVB and UVA to induce and elicit contact photoallergy in the mouse. Photodermatology7, 13–19.
69.
KaidbeyK.H., & KligmanA.M. (1978). Identification of topical photosensitizing agents in humans. Journal of Investigative Dermatology70, 149–151.
70.
GuillotJ.P., & MartiniM.C. (1985). A new method for the assessment of phototoxic and photoallergic potentials by topical applications in the albino guinea-pig. Journal of Toxicology – Cutaneous and Ocular Toxicology4, 117–133.
71.
KligmanA.M., & KaidbeyK.H. (1982). Human models for identification of photosensitizing chemicals. Journal of the National Cancer Institute69, 269–272.
72.
KochevarI.E., ZalarG.L., EinbinderJ., & HarberL.C. (1979). Assay of contact photosensitivity to musk ambrette in guinea-pigs. Journal of Investigative Dermatology73, 144–146.
73.
IchikawaH., ArmstrongR.B., & HarberL.C. (1981). Photoallergic contact dermatitis in guinea-pigs: improved induction technique using Freund's complete adjuvant. Journal of Investigative Dermatology76, 498–501.
74.
ParkerR.D., BuehlerE.V., & NewmannE.A. (1986). Phototoxicity, photoallergy and contact sensitization of nitro musk perfume raw materials. Contact Dermatitis14, 103–109.
75.
LovellW. W., & SandersD.J. (1988). Photoallergic potential in the guinea-pig of the nitromusk perfume ingredients musk ambrette, musk moskene, musk xylene, musk ketone and musk tibetene. International Journal of Cosmetic Science10, 271–279.
KaidbeyK.H., & KligmanA.M. (1981). Photo-sensitization by coumarin derivatives: structure-activity relationships. Archives of Dermatology117, 259–263.
78.
EiermannH.J. (1979). Regulatory considerations: AETT and 6-methylcoumarin. Drug and Cosmetics Industry124, 37–39.
79.
JordanW. P. (1982). The guinea-pig as a model for predicting photoallergic contact dermatitis. Contact Dermatitis8, 109–116.
80.
BuehlerE.V., NewmannE.A., & ParkerR.D. (1985). Use of the occlusive patch to evaluate the photosensitive properties of chemicals in guinea-pigs. Food and Chemical Toxicology23, 689–694.
81.
MozzanicaN., & PigattoP.D. (1990). Contact and photocontact allergy to ketoprofen: clinical and experimental study. Contact Dermatitis23, 336–340.
82.
EndoT., KatsutaT., & InoueH. (1985). Toxicological studies of ketoprofen gel-type ointment phototoxicity and photocontact sensitivity tests in guinea-pigs. Pharmacometrics40, 159–164.
83.
SchauderS., SchroderW., & GeierJ. (1996). Olaquindox-induced airborne photoallergic contact dermatitis followed by transient or persistent light reactions in 15 pig breeders. Contact Dermatitis35, 344–354.
84.
BlotzA., BlümelJ., AhrH.J., & VohrH-W. (1998). Analyses of dermal photoreactivity after oral application of fluoroquinolones with the IMDS. Immunobiology199, 3–5.
85.
EpsteinS. (1968). Chlorpromazine photosensitivity: phototoxic and photoallergic reactions. Archives of Dermatology98, 354–363.
86.
SchauderS. (1985). How to avoid phototoxic reactions in photopatch testing with chlorpromazine. Photodermatology2, 95–100.
87.
HoshinoT., IshidaK., IrieT., UekamaK., & OnoT. (1989). An attempt to reduce the photosensitizing potential of chlorpromazine with the simultaneous use of beta-cyclodextrins and dimethyl-beta cyclodextrins in guinea-pigs. Archives of Dermatological Research281, 60–65.
88.
VohrH-W., HomeyB., SchuppeH., & KindP. (1994). Photoreactions detected in a modified local lymph node assay in the mouse. Photodermatology Photoimmunology and Photomedicine10, 57–64.
89.
GiudiciP.A., & MaguireH.C. (1985). Experimental photoallergy to systemic drugs. Journal of Investigative Dermatology85, 207–211.
90.
RosenK., & SwanbeckG. (1982). Phototoxic reactions from some common drugs provoked by a high-intensity UV-A lamp. Acta Dermato-Venereologica62, 246–248.
91.
VousdenM., FergusonJ., RichardsJ., BirdN., & AllenA. (1999). Evaluation of phototoxic potential of gemifloxacin in healthy volunteers compared with ciprofloxacin. Chemotherapy45, 512–20
92.
ManI., TraynorN.J., & FergusonJ. (1999). Recent developments in fluoroquinolone photo-toxicity. Photodermatology Photoimmunology and Photomedicine15, 32–33.
93.
ManI., MurphyJ., & FergusonJ. (1999). Fluo-roquinolone phototoxicity: a comparison of moxifloxacin and lomefloxacin in normal volunteers. Journal of Antimicrobial Chemotherapy43, Suppl. B, 77–82.
94.
TraynorN.J., BarrattM.D., LovellW.W., FergusonJ., & GibbsN.K. (2000). Comparison of an in vitro cellular phototoxicity model against controlled clinical trials of fluoroquinolone skin phototoxicity. Toxicology in Vitro14, 275–283.
95.
AkterU., NiwaM., NoseT., KaidaT., MatsunoH., KozawaO., & UematsuT. (1998). Effects of several agents on UVB and UVA plus systemic fluoroquinolone-induced erythema of guinea-pig skin evaluated by reflectance colorimetry. Free Radical Biology and Medicine24, 1113–1119.
96.
MarutaniK., MatsumotoM., OtabeY., NagamutaM., TanakaK., MiyoshiA., HasegawaT., NaganoH., MatsubaraS., & KamideR. (1993). Reduced phototoxicity of a fluoroquinolone antibacterial agent with a methoxy group at the 8 position in mice irradiated with long-wavelength UV light. Antimicrobial Agents in Chemotherapy37, 2217–2223.
SchauderS. (1990). Photosensitivität nach Enoxacin und Xipamid: Kombinierte phototoxische und photoallergische Reaktion auf Enoxacin, photoallergische Reaktion auf Xipamid mit nach-folgender transienter Lichtreaktion. (Photosensitivity following enoxacin, photo-allergic reaction to xipamide with subsequent transient light reaction). Zeitschrift für Hautkrankheiten65, 253–262.
99.
IzuR., GardeazabalJ., GonzalezM., LandaN., RatonJ.A., & Diaz-PerezJ.L. (1992). Enoxacin-induced photosensitivity: study of two cases. Photodermatology Photoimmunology and Photomedicine9, 86–88.
100.
BarrattM.D., & BrownK.R. (1985). Photochemical binding of photoallergens to human serum albumin: a simple in vitro method for screening potential photoallergens. Toxicology Letters24, 1–6.
101.
LovellW. W. (1993). A scheme for in vitro screening of substances for photoallergenic potential. Toxicology in Vitro7, 95–102.
102.
LovellW. W., & JonesP.A. (2000). An evaluation of mechanistic in vitro tests for the discrimination of photoallergic and photoirritant potential. ATLA28, 707–724.
103.
De SilvaO., BasketterD., BarrattM.D., CorsiniE., CroninM.T.D., DasP.K., DegwertJ., EnkA., GarrigueJ.L., HauserC., KimberI., LepoittevinJ-P., PeguetJ., & PonecM. (1996). Alternative methods for skin sensitisation testing. The report and recommendations of ECVAM workshop 19. ATLA24, 683–705.
104.
BeckerD., KuhnU., LempertzU., EnkA., SalogaJ., & KnopJ. (1997). Flow-cytometric screening for the modulation of receptor-mediated endocytosis in human dendritic cells: implications for the development of an in vitro technique for predictive testing of contact sensitisers. Journal of Immunological Methods203, 171–180.
105.
IARC (1992). Solar and Ultraviolet Radiation: Evaluation of Carcinogenic Risks to Humans. International Agency for Research on Cancer (IARC) Monographs55, 148 pp. Lyons, France: IARC.
106.
NatarajA.J., BlackH.S., KripkeM.L., & AnanthaswamyH.N. (1995). Mechanism of induction of p53 mutation in 8-methoxypsoralen + UV-A (PUVA)-induced mouse skin cancers. Proceedings of the American Association for Cancer Research Annual Meeting36, 192.
107.
SternR.S., & LairdN. (1994). The carcinogenic risk of treatment for severe psoriasis. Cancer73, 2759–2764.
108.
SternR.S., NicholsK.T., & VäkeväL.H. (1997). Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). New England Journal of Medicine336, 1041–1045.
109.
JohnsonB.E., GibbsN.K., & FergusonJ. (1997). Quinolone antibiotic with potential to photosensitize skin tumorigenesis. Journal of Photochemistry and Photobiology B: Biology37, 171–173.
110.
KlecakG., UrbachF., & UrwylerH. (1997). Fluoroquinolone antibacterials enhance UVA-induced skin tumors. Journal of Photochemistry and Photobiology B: Biology37, 174–181.
111.
ForbesP.D. (1996). Relevance of animal models of photocarcinogenesis to humans. Photochemistry and Photobiology63, 357–362.
112.
MüllerL., KasperA., KerstenB., & ZhangJ. (1998). Photochemical genotoxicity and photochemical carcinogenesis: two sides of a coin?Toxicology Letters102–103, 383–387.
113.
AverbeckD., & MoustacchiE. (1979). Genetic effects of 3-carboxymethylpsoralen, angelicin, psoralen and 8-methoxypsoralen plus 365 nm irradiation in S. cerevisiae. Mutation Research68, 133–148.
114.
JoseJ.G. (1979). Photomutagenesis by chlorinated phenothiazine tranquilizers. Proceedings of the National Academy of Sciences USA76, 7445–7449.
115.
GomerC.J. (1980). DNA damage and repair in CHO cells following hematoporphyrin photoradiation. Cancer Letters11, 161–167.
116.
ChételatA.A., AlbertiniS., & GockeE. (1996). The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (Comet assay). Mutagenesis11, 497–504.
117.
ReavyH.J., TraynorN.J., & GibbsN.K. (1997). Photogenotoxicity of skin phototumorigenic fluoroquinolone antibiotics detected using the single cell gel electrophoresis (Comet) assay. Photochemistry and Photobiology66, 368–373.
118.
GockeE., AlbertiniS., ChetelatA.A., KirchnerS., & MusterW. (1998). The photomutagenicity of fluoroquinolones and other drugs. Toxicology Letters102–103, 375–381.
119.
BuleraS.J., TheissJ.C., FesterlingT.A., & de la IglesiaF.A. (1999). in vitro photogenotoxic activity of clinafloxacin: a paradigm predicting photocarcinogenicity. Toxicology and Applied Pharmacology156, 222–230.
120.
SnyderR.D., & CooperC.S. (1999). Photogenotoxicity of fluoroquinolones in Chinese hamster V79 cells: dependency on active topoisomerase II. Photochemistry and Photobiology69, 288–293.
121.
ChételatA.A., AlbertiniS., DrespJ.H., StrobelR., & GockeE. (1993). Photomutagenesis test development. I. 8-Methoxypsoralen, chlorpromazine and sunscreen compounds in bacterial and yeast assays. Mutation Research292, 241–250.
122.
ChételatA.A., DrespJ.H., & GockeE. (1993). Photomutagenesis test development. II. 8-Methoxypsoralen, chlorpromazine and sunscreen compounds in chromosomal aberration assays using CHO cells. Mutation Research292, 251–258.
123.
KerstenB., ZhangJ., Brendler-SchwaabS.Y., KasperP., & MüllerL. (1999). The application of the in vitro micronucleus test in Chinese hamster V79 cells to detect drug-induced photogeno-toxicity. Mutation Research445, 55–71.
124.
GockeE., MüllerL., GuzzieP.J., Brendler-SchwaabS., BuleraS., ChignellC.F., HendersonL.M., JacobsA., MurliH., SnyderR.D., & TanakaN. (2000). Considerations on photochemical genotoxicity: report of the International Workshop on Genotoxicity Test Procedures Working Group. Environmental and Molecular Muta-genesis35, 173–184.
125.
Anon (1998). European Commission, Directorate-General XXIV.The Scientific Committee On Cosmetic Products And Non-Food Products Intended For Consumers — SCCNFP/0069/98 Final. Opinion on “in vitro methods to assess phototoxicity in the safety evaluation of cosmetics ingredients or mixtures of ingredients”; adopted by the plenary session of the SCCNFP of 25 November 1998. Web site: http://europa.eu.int/comm/food/fs/sc/sccp/out49_en.html.
126.
JacobsA., AvalosJ., BrownP., & WilkinJ. (1999). Does photosensitivity predict photocarcinogenicity?International Journal of Toxicology18, 191–198.
127.
RoguetR., BeckH., BoelsmaE., BracherM., FallerC., HarrisI., LotteC., DreherF., & PonecM. (1999). Testing and improvement of reconstructed skin kits in order to elaborate European standards: first results. ATLA27, Special Issue, 333.